 Pamela Peterson
Concepts (425)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 70 | 2024 | 2135 | 6.100 |
Why?
| | Defibrillators, Implantable | 30 | 2022 | 300 | 4.800 |
Why?
| | Cardiac Resynchronization Therapy | 9 | 2022 | 45 | 2.920 |
Why?
| | Registries | 45 | 2024 | 1895 | 2.410 |
Why?
| | Ventricular Dysfunction, Left | 13 | 2023 | 385 | 2.110 |
Why?
| | Hospitalization | 32 | 2024 | 2052 | 2.080 |
Why?
| | Sexual Dysfunction, Physiological | 4 | 2024 | 64 | 2.070 |
Why?
| | Stroke Volume | 27 | 2024 | 592 | 2.060 |
Why?
| | Death, Sudden, Cardiac | 15 | 2019 | 179 | 2.050 |
Why?
| | Cardiovascular Diseases | 16 | 2025 | 2003 | 1.980 |
Why?
| | Bradycardia | 3 | 2021 | 53 | 1.870 |
Why?
| | Cancer Survivors | 5 | 2024 | 257 | 1.850 |
Why?
| | Atrial Fibrillation | 8 | 2022 | 376 | 1.730 |
Why?
| | Primary Prevention | 12 | 2019 | 188 | 1.700 |
Why?
| | Cardiology | 15 | 2022 | 261 | 1.690 |
Why?
| | American Heart Association | 18 | 2022 | 296 | 1.660 |
Why?
| | Operating Rooms | 2 | 2024 | 115 | 1.500 |
Why?
| | Aged | 95 | 2025 | 22032 | 1.290 |
Why?
| | United States | 74 | 2024 | 13826 | 1.250 |
Why?
| | Cardiac Conduction System Disease | 2 | 2018 | 3 | 1.240 |
Why?
| | Medicare | 20 | 2024 | 706 | 1.230 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 98 | 1.220 |
Why?
| | Myocardial Infarction | 19 | 2018 | 1021 | 1.180 |
Why?
| | Healthcare Disparities | 7 | 2021 | 575 | 1.170 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 10 | 2023 | 198 | 1.170 |
Why?
| | Cardiac Pacing, Artificial | 2 | 2018 | 85 | 1.170 |
Why?
| | Patient Readmission | 11 | 2024 | 652 | 1.170 |
Why?
| | Practice Guidelines as Topic | 17 | 2019 | 1497 | 1.160 |
Why?
| | Disposable Equipment | 2 | 2024 | 19 | 1.080 |
Why?
| | Cardiac Rehabilitation | 3 | 2023 | 34 | 1.080 |
Why?
| | Humans | 164 | 2025 | 129266 | 1.070 |
Why?
| | Adrenergic beta-Antagonists | 10 | 2023 | 321 | 0.980 |
Why?
| | Guideline Adherence | 12 | 2019 | 526 | 0.960 |
Why?
| | Male | 102 | 2025 | 63512 | 0.900 |
Why?
| | Practice Patterns, Physicians' | 11 | 2020 | 1267 | 0.890 |
Why?
| | Female | 104 | 2025 | 68551 | 0.890 |
Why?
| | Surgeons | 3 | 2022 | 260 | 0.880 |
Why?
| | Ventricular Function, Left | 7 | 2021 | 527 | 0.850 |
Why?
| | Aged, 80 and over | 40 | 2024 | 7055 | 0.820 |
Why?
| | Patient Discharge | 16 | 2024 | 835 | 0.810 |
Why?
| | Secondary Prevention | 6 | 2017 | 218 | 0.810 |
Why?
| | Health Status Disparities | 3 | 2021 | 251 | 0.780 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 91 | 0.770 |
Why?
| | Cardiac Resynchronization Therapy Devices | 3 | 2020 | 11 | 0.740 |
Why?
| | Anemia | 4 | 2020 | 160 | 0.720 |
Why?
| | Retrospective Studies | 35 | 2024 | 14461 | 0.720 |
Why?
| | Angiotensin Receptor Antagonists | 11 | 2023 | 89 | 0.710 |
Why?
| | Middle Aged | 59 | 2025 | 31090 | 0.700 |
Why?
| | Reminder Systems | 2 | 2025 | 173 | 0.690 |
Why?
| | Anti-Arrhythmia Agents | 4 | 2022 | 111 | 0.680 |
Why?
| | Peripheral Arterial Disease | 2 | 2024 | 457 | 0.650 |
Why?
| | Neoplasms | 5 | 2024 | 2449 | 0.630 |
Why?
| | Hospitals | 7 | 2021 | 630 | 0.630 |
Why?
| | Medication Adherence | 8 | 2025 | 556 | 0.620 |
Why?
| | Risk Factors | 30 | 2024 | 9745 | 0.610 |
Why?
| | Heart Block | 1 | 2018 | 40 | 0.610 |
Why?
| | Ventricular Function | 1 | 2018 | 61 | 0.590 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 21 | 0.590 |
Why?
| | Heart Conduction System | 1 | 2018 | 95 | 0.590 |
Why?
| | Heart Failure, Systolic | 1 | 2018 | 25 | 0.580 |
Why?
| | Stroke | 3 | 2024 | 1070 | 0.580 |
Why?
| | Cardiologists | 1 | 2018 | 45 | 0.580 |
Why?
| | Risk Assessment | 15 | 2021 | 3232 | 0.580 |
Why?
| | Birth Certificates | 1 | 2017 | 10 | 0.570 |
Why?
| | Medicaid | 3 | 2021 | 431 | 0.560 |
Why?
| | Patient Compliance | 4 | 2017 | 563 | 0.550 |
Why?
| | Congresses as Topic | 1 | 2018 | 216 | 0.540 |
Why?
| | Pregnancy Trimester, First | 1 | 2017 | 137 | 0.540 |
Why?
| | Clinical Decision-Making | 3 | 2018 | 301 | 0.540 |
Why?
| | Hospital Mortality | 8 | 2024 | 846 | 0.540 |
Why?
| | Decision Support Techniques | 5 | 2022 | 395 | 0.530 |
Why?
| | Aminobutyrates | 6 | 2023 | 33 | 0.530 |
Why?
| | Social Determinants of Health | 1 | 2020 | 220 | 0.530 |
Why?
| | Appointments and Schedules | 1 | 2017 | 84 | 0.530 |
Why?
| | Treatment Outcome | 27 | 2024 | 10202 | 0.510 |
Why?
| | Text Messaging | 3 | 2025 | 149 | 0.510 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1209 | 0.490 |
Why?
| | Patient Outcome Assessment | 2 | 2021 | 124 | 0.490 |
Why?
| | Critical Care | 2 | 2018 | 551 | 0.480 |
Why?
| | Advisory Committees | 8 | 2022 | 216 | 0.480 |
Why?
| | Prenatal Care | 1 | 2017 | 274 | 0.480 |
Why?
| | Age Factors | 11 | 2020 | 3140 | 0.470 |
Why?
| | Outpatients | 4 | 2021 | 367 | 0.470 |
Why?
| | Quality of Health Care | 6 | 2012 | 602 | 0.470 |
Why?
| | Waiting Lists | 1 | 2017 | 237 | 0.460 |
Why?
| | Patient Participation | 4 | 2022 | 414 | 0.460 |
Why?
| | Cohort Studies | 21 | 2019 | 5409 | 0.460 |
Why?
| | Decision Making | 7 | 2022 | 849 | 0.450 |
Why?
| | Health Status Indicators | 3 | 2015 | 167 | 0.440 |
Why?
| | Hemoglobins | 3 | 2020 | 339 | 0.440 |
Why?
| | Electrocardiography | 7 | 2021 | 608 | 0.440 |
Why?
| | Cardiovascular Agents | 3 | 2025 | 156 | 0.430 |
Why?
| | Insurance Coverage | 3 | 2021 | 218 | 0.420 |
Why?
| | Heart | 4 | 2023 | 637 | 0.410 |
Why?
| | Health Literacy | 2 | 2014 | 159 | 0.410 |
Why?
| | Electric Countershock | 3 | 2019 | 105 | 0.390 |
Why?
| | Heart-Assist Devices | 1 | 2018 | 539 | 0.390 |
Why?
| | Time Factors | 16 | 2024 | 6543 | 0.380 |
Why?
| | Diabetes Mellitus | 5 | 2023 | 1000 | 0.380 |
Why?
| | Stress, Psychological | 1 | 2020 | 1066 | 0.380 |
Why?
| | Acculturation | 1 | 2012 | 50 | 0.370 |
Why?
| | Glomerular Filtration Rate | 3 | 2024 | 711 | 0.370 |
Why?
| | Valsartan | 5 | 2022 | 27 | 0.370 |
Why?
| | Inpatients | 3 | 2023 | 462 | 0.370 |
Why?
| | Quality of Life | 13 | 2024 | 2687 | 0.370 |
Why?
| | Minority Groups | 2 | 2021 | 248 | 0.370 |
Why?
| | Health Status | 6 | 2012 | 754 | 0.370 |
Why?
| | Coronary Artery Disease | 3 | 2013 | 679 | 0.360 |
Why?
| | Biphenyl Compounds | 5 | 2022 | 60 | 0.360 |
Why?
| | Tetrazoles | 5 | 2023 | 38 | 0.350 |
Why?
| | Heart Transplantation | 1 | 2017 | 721 | 0.350 |
Why?
| | Arrhythmias, Cardiac | 3 | 2019 | 317 | 0.340 |
Why?
| | Coronary Disease | 3 | 2008 | 385 | 0.340 |
Why?
| | Health Services Accessibility | 1 | 2017 | 899 | 0.340 |
Why?
| | Hospitals, Pediatric | 2 | 2024 | 508 | 0.320 |
Why?
| | Young Adult | 9 | 2024 | 12391 | 0.320 |
Why?
| | Metformin | 2 | 2023 | 315 | 0.310 |
Why?
| | Sex Factors | 8 | 2018 | 1965 | 0.310 |
Why?
| | Catheter Ablation | 1 | 2012 | 335 | 0.300 |
Why?
| | Physician-Patient Relations | 4 | 2021 | 538 | 0.280 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2023 | 566 | 0.280 |
Why?
| | Neprilysin | 4 | 2021 | 48 | 0.270 |
Why?
| | Quality Improvement | 4 | 2021 | 1095 | 0.270 |
Why?
| | Equipment Design | 4 | 2017 | 513 | 0.270 |
Why?
| | Adult | 23 | 2024 | 35495 | 0.270 |
Why?
| | Survivors | 2 | 2009 | 457 | 0.260 |
Why?
| | Ventricular Remodeling | 2 | 2018 | 255 | 0.260 |
Why?
| | Aftercare | 6 | 2023 | 203 | 0.260 |
Why?
| | Follow-Up Studies | 13 | 2021 | 4887 | 0.250 |
Why?
| | Cross-Sectional Studies | 11 | 2022 | 5050 | 0.250 |
Why?
| | Mineralocorticoid Receptor Antagonists | 3 | 2020 | 46 | 0.250 |
Why?
| | Exercise Tolerance | 1 | 2008 | 273 | 0.250 |
Why?
| | Kidney Diseases | 1 | 2009 | 382 | 0.240 |
Why?
| | Social Support | 5 | 2014 | 582 | 0.240 |
Why?
| | Self Care | 4 | 2018 | 365 | 0.240 |
Why?
| | Postoperative Complications | 2 | 2024 | 2473 | 0.240 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2024 | 430 | 0.240 |
Why?
| | Prone Position | 1 | 2005 | 30 | 0.240 |
Why?
| | Supine Position | 1 | 2005 | 38 | 0.230 |
Why?
| | Exercise Test | 4 | 2008 | 612 | 0.230 |
Why?
| | Diabetes Complications | 1 | 2006 | 224 | 0.230 |
Why?
| | Informed Consent | 2 | 2023 | 167 | 0.230 |
Why?
| | Child | 7 | 2024 | 20785 | 0.230 |
Why?
| | Atherosclerosis | 2 | 2024 | 402 | 0.230 |
Why?
| | Insurance, Health | 2 | 2017 | 265 | 0.230 |
Why?
| | Evidence-Based Medicine | 4 | 2013 | 712 | 0.230 |
Why?
| | Survival Analysis | 6 | 2019 | 1269 | 0.220 |
Why?
| | Artifacts | 1 | 2005 | 126 | 0.220 |
Why?
| | Heart Diseases | 1 | 2008 | 350 | 0.220 |
Why?
| | Quality Assurance, Health Care | 4 | 2010 | 317 | 0.220 |
Why?
| | Survival Rate | 7 | 2019 | 1869 | 0.220 |
Why?
| | Qualitative Research | 3 | 2021 | 1215 | 0.220 |
Why?
| | Cardiovascular Abnormalities | 1 | 2024 | 13 | 0.220 |
Why?
| | Image Enhancement | 1 | 2005 | 167 | 0.220 |
Why?
| | Adolescent | 7 | 2024 | 20313 | 0.220 |
Why?
| | Sex Characteristics | 1 | 2009 | 736 | 0.220 |
Why?
| | Odds Ratio | 7 | 2017 | 1019 | 0.210 |
Why?
| | Fee-for-Service Plans | 2 | 2014 | 87 | 0.210 |
Why?
| | Depression | 7 | 2024 | 1306 | 0.210 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 2 | 2021 | 36 | 0.210 |
Why?
| | Predictive Value of Tests | 7 | 2018 | 1949 | 0.210 |
Why?
| | Incidence | 6 | 2019 | 2636 | 0.210 |
Why?
| | Drug Combinations | 5 | 2022 | 330 | 0.210 |
Why?
| | Risk | 3 | 2019 | 854 | 0.210 |
Why?
| | Heart Rate | 3 | 2019 | 802 | 0.210 |
Why?
| | Multicenter Studies as Topic | 2 | 2024 | 285 | 0.210 |
Why?
| | Atherectomy | 1 | 2023 | 36 | 0.200 |
Why?
| | Vascular Patency | 1 | 2023 | 102 | 0.200 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2020 | 1365 | 0.200 |
Why?
| | Popliteal Artery | 1 | 2023 | 58 | 0.200 |
Why?
| | Movement | 1 | 2005 | 269 | 0.200 |
Why?
| | Coated Materials, Biocompatible | 1 | 2023 | 59 | 0.200 |
Why?
| | Social Class | 2 | 2017 | 258 | 0.200 |
Why?
| | Mortality | 4 | 2017 | 307 | 0.200 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2022 | 21 | 0.200 |
Why?
| | Prognosis | 9 | 2022 | 3773 | 0.200 |
Why?
| | Cardiac Surgical Procedures | 4 | 2010 | 499 | 0.200 |
Why?
| | Colorado | 6 | 2017 | 4406 | 0.190 |
Why?
| | Refusal to Participate | 1 | 2021 | 6 | 0.190 |
Why?
| | Acute Kidney Injury | 2 | 2024 | 790 | 0.190 |
Why?
| | Seasons | 1 | 2024 | 496 | 0.190 |
Why?
| | Adenoidectomy | 1 | 2022 | 65 | 0.190 |
Why?
| | Femoral Artery | 1 | 2023 | 173 | 0.190 |
Why?
| | Multivariate Analysis | 11 | 2017 | 1497 | 0.190 |
Why?
| | Linear Models | 5 | 2017 | 819 | 0.190 |
Why?
| | Hospital Costs | 1 | 2022 | 114 | 0.190 |
Why?
| | Longitudinal Studies | 5 | 2018 | 2715 | 0.190 |
Why?
| | Surgical Procedures, Operative | 1 | 2024 | 244 | 0.180 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2021 | 58 | 0.180 |
Why?
| | Surveys and Questionnaires | 10 | 2022 | 5384 | 0.180 |
Why?
| | Hydroxychloroquine | 1 | 2021 | 55 | 0.180 |
Why?
| | Patient Reported Outcome Measures | 2 | 2024 | 372 | 0.180 |
Why?
| | Health Care Costs | 1 | 2024 | 367 | 0.180 |
Why?
| | Manufacturing Industry | 1 | 2020 | 4 | 0.180 |
Why?
| | Intestinal Obstruction | 1 | 2021 | 49 | 0.180 |
Why?
| | Comorbidity | 7 | 2023 | 1544 | 0.180 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2439 | 0.180 |
Why?
| | Interrupted Time Series Analysis | 1 | 2021 | 53 | 0.180 |
Why?
| | Chi-Square Distribution | 5 | 2017 | 514 | 0.180 |
Why?
| | Protease Inhibitors | 1 | 2021 | 106 | 0.170 |
Why?
| | Prosthesis Implantation | 2 | 2019 | 143 | 0.170 |
Why?
| | Patient Care | 1 | 2021 | 108 | 0.170 |
Why?
| | Groundwater | 1 | 2021 | 36 | 0.170 |
Why?
| | Exercise | 3 | 2009 | 1925 | 0.170 |
Why?
| | Clinical Trials as Topic | 4 | 2015 | 1004 | 0.170 |
Why?
| | Intensive Care Units | 2 | 2018 | 736 | 0.170 |
Why?
| | Goals | 2 | 2020 | 159 | 0.170 |
Why?
| | Prospective Studies | 11 | 2018 | 7123 | 0.170 |
Why?
| | Research Personnel | 1 | 2021 | 155 | 0.170 |
Why?
| | Confidence Intervals | 2 | 2012 | 316 | 0.170 |
Why?
| | Algorithms | 2 | 2021 | 1613 | 0.170 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 147 | 0.160 |
Why?
| | Income | 1 | 2020 | 188 | 0.160 |
Why?
| | Length of Stay | 3 | 2024 | 1120 | 0.160 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2020 | 59 | 0.160 |
Why?
| | Logistic Models | 7 | 2015 | 1985 | 0.150 |
Why?
| | Antirheumatic Agents | 1 | 2021 | 280 | 0.150 |
Why?
| | Hypertension | 3 | 2021 | 1242 | 0.150 |
Why?
| | Multimorbidity | 1 | 2019 | 46 | 0.150 |
Why?
| | Personal Satisfaction | 1 | 2020 | 200 | 0.150 |
Why?
| | Societies, Medical | 3 | 2019 | 744 | 0.150 |
Why?
| | Research Design | 2 | 2023 | 1043 | 0.150 |
Why?
| | Fraud | 1 | 2018 | 9 | 0.150 |
Why?
| | Medical Overuse | 1 | 2018 | 30 | 0.150 |
Why?
| | Minority Health | 1 | 2018 | 19 | 0.150 |
Why?
| | Hospitals, Rural | 1 | 2018 | 37 | 0.150 |
Why?
| | Patient Selection | 4 | 2021 | 662 | 0.150 |
Why?
| | Computers, Handheld | 1 | 2018 | 23 | 0.140 |
Why?
| | Social Values | 1 | 2018 | 33 | 0.140 |
Why?
| | Subacute Care | 1 | 2018 | 73 | 0.140 |
Why?
| | Bundle-Branch Block | 2 | 2017 | 30 | 0.140 |
Why?
| | Hospitals, Urban | 1 | 2018 | 129 | 0.140 |
Why?
| | Efficiency, Organizational | 1 | 2018 | 133 | 0.140 |
Why?
| | Treatment Refusal | 2 | 2008 | 89 | 0.140 |
Why?
| | Coronary Angiography | 3 | 2008 | 305 | 0.140 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 369 | 0.140 |
Why?
| | Cause of Death | 3 | 2019 | 392 | 0.130 |
Why?
| | Warfarin | 1 | 2017 | 147 | 0.130 |
Why?
| | Prosthesis Design | 1 | 2018 | 306 | 0.130 |
Why?
| | Thromboembolism | 1 | 2017 | 112 | 0.130 |
Why?
| | Prevalence | 5 | 2022 | 2553 | 0.130 |
Why?
| | Publishing | 1 | 2018 | 140 | 0.130 |
Why?
| | Medically Uninsured | 1 | 2017 | 126 | 0.130 |
Why?
| | Proportional Hazards Models | 4 | 2019 | 1197 | 0.130 |
Why?
| | Nurse Practitioners | 1 | 2018 | 132 | 0.120 |
Why?
| | Quality Indicators, Health Care | 1 | 2018 | 298 | 0.120 |
Why?
| | Racism | 1 | 2018 | 127 | 0.120 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2018 | 248 | 0.120 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2021 | 467 | 0.120 |
Why?
| | Health Policy | 1 | 2017 | 351 | 0.110 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 1094 | 0.110 |
Why?
| | Mental Health | 1 | 2020 | 685 | 0.110 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2020 | 1276 | 0.110 |
Why?
| | Hyperkalemia | 1 | 2013 | 24 | 0.110 |
Why?
| | Kidney | 1 | 2021 | 1385 | 0.110 |
Why?
| | Heart Ventricles | 1 | 2018 | 781 | 0.110 |
Why?
| | Systole | 2 | 2013 | 191 | 0.100 |
Why?
| | Cardiotonic Agents | 1 | 2014 | 126 | 0.100 |
Why?
| | Software | 1 | 2018 | 606 | 0.100 |
Why?
| | Hemodialysis Units, Hospital | 1 | 2012 | 5 | 0.100 |
Why?
| | Infant | 2 | 2024 | 8975 | 0.100 |
Why?
| | Severity of Illness Index | 3 | 2010 | 2740 | 0.100 |
Why?
| | Vascular Access Devices | 1 | 2012 | 26 | 0.100 |
Why?
| | Medical Staff | 1 | 2012 | 16 | 0.100 |
Why?
| | Anticoagulants | 1 | 2017 | 636 | 0.100 |
Why?
| | Child, Preschool | 2 | 2024 | 10459 | 0.100 |
Why?
| | Physicians | 1 | 2020 | 859 | 0.100 |
Why?
| | Models, Educational | 1 | 2012 | 88 | 0.100 |
Why?
| | Communication | 1 | 2018 | 836 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 2 | 2016 | 851 | 0.100 |
Why?
| | Antihypertensive Agents | 2 | 2023 | 485 | 0.090 |
Why?
| | Evidence-Based Practice | 2 | 2013 | 212 | 0.090 |
Why?
| | Forecasting | 2 | 2024 | 359 | 0.090 |
Why?
| | Drug Prescriptions | 1 | 2013 | 247 | 0.090 |
Why?
| | Angina Pectoris | 2 | 2010 | 67 | 0.090 |
Why?
| | Vocabulary | 1 | 2011 | 46 | 0.090 |
Why?
| | Peripheral Vascular Diseases | 1 | 2011 | 101 | 0.090 |
Why?
| | Ambulatory Care Facilities | 1 | 2012 | 226 | 0.090 |
Why?
| | Pilot Projects | 3 | 2021 | 1584 | 0.090 |
Why?
| | Bacteremia | 1 | 2012 | 194 | 0.090 |
Why?
| | Managed Care Programs | 1 | 2011 | 133 | 0.090 |
Why?
| | Contraindications | 1 | 2010 | 90 | 0.080 |
Why?
| | Renin-Angiotensin System | 2 | 2023 | 82 | 0.080 |
Why?
| | Women's Health Services | 1 | 2010 | 16 | 0.080 |
Why?
| | Patient-Centered Care | 1 | 2015 | 505 | 0.080 |
Why?
| | Cooperative Behavior | 1 | 2012 | 433 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2009 | 3080 | 0.080 |
Why?
| | Palliative Care | 2 | 2019 | 706 | 0.080 |
Why?
| | Diuretics | 2 | 2020 | 75 | 0.080 |
Why?
| | Probability | 1 | 2010 | 305 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2012 | 504 | 0.070 |
Why?
| | ROC Curve | 1 | 2009 | 503 | 0.070 |
Why?
| | Coronary Care Units | 1 | 2007 | 18 | 0.070 |
Why?
| | Myocardial Reperfusion | 1 | 2007 | 50 | 0.070 |
Why?
| | Emergency Service, Hospital | 2 | 2010 | 1896 | 0.070 |
Why?
| | Chest Pain | 1 | 2007 | 88 | 0.070 |
Why?
| | Caregivers | 1 | 2014 | 809 | 0.070 |
Why?
| | Women's Health | 1 | 2010 | 364 | 0.070 |
Why?
| | Emotions | 1 | 2012 | 538 | 0.070 |
Why?
| | Myocardial Ischemia | 2 | 2019 | 258 | 0.070 |
Why?
| | Research Report | 2 | 2017 | 76 | 0.070 |
Why?
| | Health Personnel | 1 | 2012 | 648 | 0.070 |
Why?
| | Angina, Unstable | 1 | 2006 | 76 | 0.060 |
Why?
| | Weight Loss | 2 | 2009 | 732 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 339 | 0.060 |
Why?
| | Cardiac Output, Low | 1 | 2006 | 66 | 0.060 |
Why?
| | Renal Dialysis | 2 | 2024 | 423 | 0.060 |
Why?
| | Diagnostic Errors | 1 | 2006 | 162 | 0.060 |
Why?
| | Consensus | 2 | 2019 | 615 | 0.060 |
Why?
| | Sickness Impact Profile | 1 | 2005 | 55 | 0.060 |
Why?
| | Physical Endurance | 1 | 2006 | 262 | 0.060 |
Why?
| | Pregnancy | 1 | 2017 | 6390 | 0.060 |
Why?
| | Radionuclide Imaging | 1 | 2005 | 123 | 0.060 |
Why?
| | Heart Valves | 1 | 2005 | 42 | 0.060 |
Why?
| | New York | 1 | 2024 | 128 | 0.060 |
Why?
| | Recovery of Function | 1 | 2008 | 641 | 0.060 |
Why?
| | Depressive Disorder | 1 | 2007 | 366 | 0.060 |
Why?
| | Weight Gain | 1 | 2007 | 509 | 0.050 |
Why?
| | Electronic Health Records | 1 | 2011 | 970 | 0.050 |
Why?
| | Acute Disease | 1 | 2006 | 978 | 0.050 |
Why?
| | Overweight | 1 | 2007 | 531 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 253 | 0.050 |
Why?
| | Biomedical Research | 1 | 2008 | 637 | 0.050 |
Why?
| | Sodium | 1 | 2023 | 205 | 0.050 |
Why?
| | Patients | 1 | 2024 | 167 | 0.050 |
Why?
| | Home Care Services | 1 | 2024 | 225 | 0.050 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2021 | 62 | 0.050 |
Why?
| | Adhesives | 1 | 2021 | 13 | 0.050 |
Why?
| | Medical Oncology | 1 | 2024 | 270 | 0.050 |
Why?
| | Tissue Adhesions | 1 | 2021 | 30 | 0.050 |
Why?
| | Disease Management | 2 | 2017 | 588 | 0.050 |
Why?
| | Population Health | 1 | 2021 | 46 | 0.040 |
Why?
| | Trust | 1 | 2021 | 115 | 0.040 |
Why?
| | Transferrins | 1 | 2020 | 1 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 35 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1839 | 0.040 |
Why?
| | Transferrin | 1 | 2020 | 42 | 0.040 |
Why?
| | Ferritins | 1 | 2020 | 58 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 469 | 0.040 |
Why?
| | Intestines | 1 | 2022 | 347 | 0.040 |
Why?
| | Patient Safety | 2 | 2012 | 285 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 300 | 0.040 |
Why?
| | United States Government Agencies | 1 | 2018 | 6 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 569 | 0.040 |
Why?
| | Health Care Surveys | 2 | 2010 | 557 | 0.040 |
Why?
| | Cardiovascular Nursing | 1 | 2018 | 3 | 0.040 |
Why?
| | Transitional Care | 1 | 2018 | 36 | 0.040 |
Why?
| | Aspirin | 2 | 2015 | 380 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 1001 | 0.040 |
Why?
| | F Factor | 1 | 2017 | 3 | 0.040 |
Why?
| | Tachycardia, Ventricular | 1 | 2019 | 167 | 0.040 |
Why?
| | Health Facility Size | 1 | 2017 | 11 | 0.030 |
Why?
| | Focus Groups | 1 | 2020 | 450 | 0.030 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 272 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 359 | 0.030 |
Why?
| | Hospitals, Teaching | 1 | 2017 | 113 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2014 | 2011 | 0.030 |
Why?
| | Mass Screening | 1 | 2024 | 1149 | 0.030 |
Why?
| | Cerebrovascular Disorders | 1 | 2017 | 90 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2020 | 412 | 0.030 |
Why?
| | Biomarkers | 2 | 2017 | 3968 | 0.030 |
Why?
| | Information Dissemination | 1 | 2018 | 205 | 0.030 |
Why?
| | Skilled Nursing Facilities | 1 | 2017 | 130 | 0.030 |
Why?
| | Administration, Oral | 1 | 2017 | 785 | 0.030 |
Why?
| | Frail Elderly | 1 | 2015 | 121 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2023 | 1219 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1716 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 991 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2018 | 632 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 279 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1481 | 0.030 |
Why?
| | Potassium | 1 | 2013 | 143 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2010 | 3628 | 0.030 |
Why?
| | Comparative Effectiveness Research | 1 | 2014 | 148 | 0.030 |
Why?
| | Databases, Factual | 1 | 2018 | 1266 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2014 | 399 | 0.030 |
Why?
| | Hemorrhage | 1 | 2017 | 678 | 0.030 |
Why?
| | Propensity Score | 1 | 2014 | 263 | 0.030 |
Why?
| | Pacific States | 1 | 2012 | 6 | 0.020 |
Why?
| | Dementia | 1 | 2015 | 225 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1708 | 0.020 |
Why?
| | New England | 1 | 2012 | 30 | 0.020 |
Why?
| | Health Maintenance Organizations | 1 | 2012 | 97 | 0.020 |
Why?
| | Drug Utilization Review | 1 | 2012 | 57 | 0.020 |
Why?
| | Needs Assessment | 1 | 2014 | 359 | 0.020 |
Why?
| | Education | 1 | 2012 | 100 | 0.020 |
Why?
| | Recurrence | 1 | 2015 | 1005 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2013 | 265 | 0.020 |
Why?
| | Creatinine | 1 | 2013 | 491 | 0.020 |
Why?
| | Internationality | 1 | 2012 | 149 | 0.020 |
Why?
| | History, 21st Century | 1 | 2012 | 183 | 0.020 |
Why?
| | Infection Control | 1 | 2012 | 140 | 0.020 |
Why?
| | Drug Utilization | 1 | 2012 | 171 | 0.020 |
Why?
| | History, 20th Century | 1 | 2012 | 291 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 442 | 0.020 |
Why?
| | Pacemaker, Artificial | 1 | 2012 | 110 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 479 | 0.020 |
Why?
| | Lung Diseases | 1 | 2017 | 739 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5736 | 0.020 |
Why?
| | Poisson Distribution | 1 | 2010 | 73 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 203 | 0.020 |
Why?
| | Terminal Care | 1 | 2012 | 214 | 0.020 |
Why?
| | Eligibility Determination | 1 | 2009 | 63 | 0.020 |
Why?
| | Myocardial Revascularization | 1 | 2008 | 72 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 983 | 0.020 |
Why?
| | Databases as Topic | 1 | 2007 | 59 | 0.020 |
Why?
| | Blood Pressure Determination | 1 | 2008 | 148 | 0.020 |
Why?
| | Reperfusion | 1 | 2006 | 38 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2009 | 251 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2009 | 505 | 0.010 |
Why?
| | Clinical Competence | 1 | 2012 | 1016 | 0.010 |
Why?
| | California | 1 | 2006 | 400 | 0.010 |
Why?
| | Referral and Consultation | 1 | 2010 | 727 | 0.010 |
Why?
| | Family | 1 | 2009 | 644 | 0.010 |
Why?
| | Interviews as Topic | 1 | 2007 | 705 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 405 | 0.010 |
Why?
| | Coronary Artery Bypass | 1 | 2005 | 224 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2009 | 763 | 0.010 |
Why?
| | Anxiety | 1 | 2009 | 962 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2009 | 892 | 0.010 |
Why?
| | Diet | 1 | 2009 | 1212 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1736 | 0.010 |
Why?
| | Blood Glucose | 1 | 2010 | 2097 | 0.010 |
Why?
| | Body Mass Index | 1 | 2007 | 2272 | 0.010 |
Why?
| | Obesity | 1 | 2007 | 2879 | 0.010 |
Why?
|
|
Peterson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|